Apogee Therapeutics, Inc.
APGEDelisted Sep 3, 2026- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001974640
Apogee Therapeutics, Inc. was delisted on Sep 3, 2026; its insiders filed their last Form 4 on Sep 3, 2026; 288 institutions reported holding it in 13F filings for Q2 2026, worth $8.93B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q4 2025
Institutional positions in Apogee Therapeutics, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 207
- +35 vs. Q3 2025
- Shares held
- 69.8M
- +10.2M (+17.2%) vs. Q3 2025
- Total value
- $5.27B
- +$2.90B (+122.6%) vs. Q3 2025
- New holders
- 53
- 86 more added
- Sold out
- 18
- 46 more reduced
2 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting APGE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 288 | $8.93B |
| Q1 2026 | 224 | $6.64B |
| Q4 2025 | 207 | $5.27B |
| Q3 2025 | 174 | $2.37B |
| Q2 2025 | 183 | $2.51B |
| Q1 2025 | 169 | $2.30B |
| Q4 2024 | 158 | $2.62B |
| Q3 2024 | 139 | $3.29B |
| Q2 2024 | 139 | $2.13B |
| Q1 2024 | 139 | $3.52B |
| Q4 2023 | 85 | $1.16B |
| Q3 2023 | 73 | $848.7M |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Apogee Therapeutics, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| RTW Investments, LP | 2,712,097 | $204.7M | 2.05% | 00.0% | Unchanged |
| T. Rowe Price Investment Management, Inc. | 2,732,456 | $206.2M | 0.13% | +2,731,015+189,522.2% | Added |
| Vanguard Group Inc | 2,857,824 | $215.7M | 0.00% | +612,193+27.3% | Added |
| BlackRock, Inc. | 3,783,994 | $285.6M | 0.00% | +1,097,968+40.9% | Added |
| Wellington Management Group LLP | 4,746,585 | $358.3M | 0.06% | +22,884+0.5% | Added |
| FMR LLC | 8,225,038 | $620.8M | 0.03% | +1,308,576+18.9% | Added |
| VR Adviser, LLC | 8,493,321 | $641.1M | 31.67% | 00.0% | Unchanged |
| Jefferies Financial Group Inc. | 0 | $0 | 0.00% | −568,084−100.0% | Sold out |
| Commodore Capital LP | 0 | $0 | 0.00% | −290,000−100.0% | Sold out |
| Tang Capital Management LLC | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| Exome Asset Management LLC | 0 | $0 | 0.00% | −94,400−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −72,348−100.0% | Sold out |
| Diadema Partners LP | 0 | $0 | 0.00% | −64,250−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −39,332−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −37,535−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −26,241−100.0% | Sold out |
| Natixis Advisors, L.P. | 0 | $0 | 0.00% | −12,475−100.0% | Sold out |
| Family Management Corp | 0 | $0 | 0.00% | −5,589−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −4,800−100.0% | Sold out |
| Caitong International Asset Management Co., Ltd | 0 | $0 | 0.00% | −97−100.0% | Sold out |
| Washington Trust Advisors, Inc. | 0 | $0 | 0.00% | −96−100.0% | Sold out |
| Rise Advisors, LLC | 0 | $0 | 0.00% | −16−100.0% | Sold out |
| Federation des caisses Desjardins du Quebec | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Principal Securities, Inc. | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Montag A & Associates Inc | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| AXA Investment Managers S.A. | – | – | – | – | Not filed |
| Glenmede Investment Management, LP | – | – | – | – | Not filed |